Insomnia and Mindfulness Stress Reduction Program

Sponsor
NURDİLAN SENER (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05202054
Collaborator
(none)
180
1
5.8

Study Details

Study Description

Brief Summary

Menopause is the longest life stage in a woman's life, in which psychological and social changes are experienced as well as physical changes and some health problems occur. The symptoms of menopause develop due to varying degrees of somatic and psychological changes that occur as a result of the gradual loss of function of the ovaries. One of the most common and disturbing symptoms of menopause is sleep problems. Sleep is seen as an important health variable that affects an individual's quality of life and well-being. The need for sleep is included among the basic care problems by nursing theorists, and sleep-related problems are included as a nursing diagnosis in the nursing literature. In the literature, it has been stated that mindfulness stress reduction program reduces menopausal symptoms.

Nurses should have knowledge about menopause and coping methods in the field. Although the number of studies examining the effect of mindfulness stress reduction program on insomnia, which is one of the menopausal complaints, is very few in the literature.

Condition or Disease Intervention/Treatment Phase
  • Other: mindfulness stress reduction program
N/A

Detailed Description

Menopause is a medical term defined as the absence of menstrual bleeding lasting more than one year in women in a certain period of life. Menopause is the longest life stage in a woman's life, in which psychological and social changes are experienced as well as physical changes and some health problems occur. The symptoms of menopause develop due to varying degrees of somatic and psychological changes that occur as a result of the gradual loss of function of the ovaries. One of the most common and disturbing symptoms of menopause is sleep problems.

Sleep is accepted as one of the basic physiological needs of humans, which covers 1/3 of human life and ensures the continuity of health. In addition to productivity and efficiency, sleep positively affects cognitive functions such as memory and concentration and contributes to physical and psychological restoration. Because of these positive effects, sleep is seen as an important health variable that affects an individual's quality of life and well-being.

The need for sleep is included among the basic care problems by nursing theorists, and sleep-related problems are included as a nursing diagnosis in the nursing literature. "Discomfort in sleep pattern", which is defined as a condition that causes discomfort in the quality and quantity of the resting pattern or affects the lifestyle, is an important nursing diagnosis that also affects the quality of life and is among the nursing diagnoses determined by NANDA (North American Nursing Diagnosis Association).

In order to cope with the problems participan experience in the menopausal period, women seek various pharmacological and non-pharmacological ways. When the studies conducted in recent years are examined, it has been determined that the commonly used complementary alternative therapies reduce the complaints experienced in menopause. One of the complementary alternative therapies is mindfulness. In the literature, it has been stated that mindfulness stress reduction program reduces menopausal symptoms.

Nurses should have knowledge about menopause and coping methods in the field. Counseling the individual and the family is among the responsibilities of the nurse. Although the number of studies examining the effect of mindfulness stress reduction program and acupuncture on insomnia, which is one of the menopausal complaints, is very few in the literature. It is thought that this study, which was designed to examine the effect of mindfulness stress reduction program on insomnia and quality of life from menopausal complaints, will provide evidence and bring innovation to nursing profession practices.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
180 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
EXPERIMENTAL RANDOMIZED STUDYEXPERIMENTAL RANDOMIZED STUDY
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Mindfulness Stress Reduction Program Applied to Postmenopausal Women on Insomnia and Quality of Life
Anticipated Study Start Date :
Feb 3, 2022
Anticipated Primary Completion Date :
Apr 3, 2022
Anticipated Study Completion Date :
Jul 29, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: The Effect of mindfulness stress reduction program on slepness and quality of life

Groups of 20 will be formed for the implementation of the mindfulness stress reduction program in the experimental group. The BFSAP day and time will be determined by taking into account the time zones where women are available. 150 minutes of BFSAP will be applied to the women in the experimental group once a week, lasting 8 weeks and consisting of 8 times in total. The women will then be given a midterm test. After the midterm, women will be asked to individually repeat the BFSAP application in their own home for 8 weeks (weeks 8-16).

Other: mindfulness stress reduction program
Before the program is implemented, in case women forget, they will be called and reminded of the training time, and they will be invited to the program. The women in the experimental group will be administered 150 minutes of BFSAP once a week, lasting 8 weeks, and consisting of 8 times in total. Afterwards, the women will be given an intermediate test. After the midterm test, women will be asked to individually repeat their BFSAP administration in their own home for 8 weeks (weeks 8-16).

Outcome Measures

Primary Outcome Measures

  1. women's health initiative insomnia scale [UP TO 16 WEEKS]

    Levine et al. (2003) the validity and reliability study of the scale in our country was done by Timur and Şahin (2009). The scale is a Likert type scale consisting of 5 questions. In the study of Timur and Şahin (2009), the Cronbach Alpha value was found to be 0.85.

Secondary Outcome Measures

  1. Menopause-Specific Quality of Life Scale [up to 16 weeks]

    The scale was developed by Hilditch et al. in 1996 to measure menopause-specific quality of life. It was adapted to Turkish society by Kharbouch and Şahin in 2005 and its validity and reliability were determined. The scale is a 7-point Likert type scale consisting of 29 questions. Each sub-domain score was scored from 0 to 6 in the MCQC. "0" points that there is no problem with that issue. A score of "1" indicates that the problem exists, but this problem is not disturbing at all, while scores between 2-6 indicate the severity and increasing levels of the existing problem. The lowest score that can be obtained from the scale is 0, the highest score is 174. The scale consists of four sub-dimensions: vasomotor, psychosocial, physical and sexual. As the score increases, the severity of the complaint increases and the quality of life decreases.

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 70 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • being able to read and write,

  • Not having a period for at least a year,

  • Not having any diagnosed psychiatric disease or not using medication,

  • Not using or not using hormone replacement therapy.

Exclusion Criteria:
  • To have entered menopause with surgical methods,

  • Not participating in at least two group programs.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • NURDİLAN SENER

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NURDİLAN SENER, principal investigator, Firat University
ClinicalTrials.gov Identifier:
NCT05202054
Other Study ID Numbers:
  • FIRAT UNIVERSTY
First Posted:
Jan 21, 2022
Last Update Posted:
Feb 3, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by NURDİLAN SENER, principal investigator, Firat University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 3, 2022